期刊
BIOCHEMISTRY
卷 49, 期 44, 页码 9488-9497出版社
AMER CHEMICAL SOC
DOI: 10.1021/bi1013134
关键词
-
资金
- National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH)
- NIH [NS045585]
We report the results of solid state nuclear magnetic resonance (NMR) measurements on amyloid fibrils formed by the full-length prion protein PrP (residues 23-231, Syrian hamster sequence). Measurements of intermolecular C-13-C-13 dipole-dipole couplings in selectively carbonyl-labeled samples indicate that beta-sheets in these fibrils have an in-register parallel structure, as previously observed in amyloid fibrils associated with Alzheimer's disease and type 2 diabetes and in yeast prion fibrils. Two-dimensional C-13-C-13 and N-15-C-13 solid state NMR spectra of a uniformly N-15- and C-13-labeled sample indicate that a relatively small fraction of the full sequence, localized to the C-terminal end, forms the structurally ordered, immobilized core. Although unique site-specific assignments of the solid state NMR signals cannot be obtained from these spectra, analysis with a Monte Carlo/simulated annealing algorithm suggests that the core is comprised primarily of residues in the 173-224 range. These results are consistent with earlier electron paramagnetic resonance studies of fibrils formed by residues 90-231 of the human PrP sequence, formed under somewhat different conditions [Cobb, N. J., Sonnichsen, F. D., McHaourab, H., and Surewicz, W. K. (2007) Proc. Natl. Acad. Sci. U.S.A. 104, 18946-18951], suggesting that an in-register parallel beta-sheet structure formed by the C-terminal end may be a general feature of PrP fibrils prepared in vitro.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据